Turnstone Biologics Corp. (TSBX)
NASDAQ: TSBX · IEX Real-Time Price · USD
2.700
0.00 (0.00%)
At close: Jun 17, 2024, 4:00 PM
2.720
+0.020 (0.74%)
Pre-market: Jun 18, 2024, 7:12 AM EDT

Turnstone Biologics Stock Forecast

Stock Price Forecast

The 2 analysts with 12-month price forecasts for Turnstone Biologics stock have an average target of 19, with a low estimate of 18 and a high estimate of 20. The average target predicts an increase of 603.70% from the current stock price of 2.70.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $18 $19 $20 $20
Change +566.67% +603.70% +640.74% +640.74%
* Price targets were last updated on Aug 15, 2023.

Analyst Ratings

The average analyst rating for TSBX stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Aug '23
Strong Buy 1
Buy 1
Hold 0
Sell 0
Strong Sell 0
Total 2

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
B of A Securities
B of A Securities
Strong Buy
Initiates
$18
Strong Buy Initiates $18 +566.67% Aug 15, 2023
Piper Sandler
Piper Sandler
Buy
Initiates
$20
Buy Initiates $20 +640.74% Aug 15, 2023
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
from 19.31M
Revenue Next Year
n/a
EPS This Year
-3.51
from -4.78
EPS Next Year
-2.61
from -3.51
Year 20212022202320242025202620272028
Revenue
101.29M73.30M19.31M-----
Revenue Growth
--27.64%-73.66%-----
EPS
0.16-12.49-4.78-3.51-2.61-3.05--
EPS Growth
--------
Forward PE
--------
No. Analysts ---55444
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20242025202620272028
High n/a n/a n/a n/a n/a
Avg n/a n/a n/a n/a n/a
Low n/a n/a n/a n/a n/a

Revenue Growth

Revenue Growth 20242025202620272028
High - - - - -
Avg - - - - -
Low - - - - -

EPS Forecast

EPS 202420252026
High -3.02 -2.49 -3.14
Avg -3.51 -2.61 -3.05
Low -4.40 -2.69 -2.93

EPS Growth

EPS Growth 202420252026
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.